The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksComputacenter Regulatory News (CCC)

Share Price Information for Computacenter (CCC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,588.00
Bid: 2,590.00
Ask: 2,596.00
Change: 58.00 (2.29%)
Spread: 6.00 (0.232%)
Open: 2,586.00
High: 2,594.00
Low: 2,542.00
Prev. Close: 2,530.00
CCC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

17 May 2023 14:00

RNS Number : 7673Z
Computacenter PLC
17 May 2023
 

Computacenter plc

Incorporated in England

Registration number: 03110569

LEI: 549300XSXUZ1I19DB105

ISIN: GB00BV9FP302

 

Computacenter plc

 

RESULTS OF ANNUAL GENERAL MEETING 17 MAY 2023

 

All resolutions put to the meeting were duly passed on a poll. The poll results showing the number of votes received for and against each resolution are shown below. Resolutions 1 to 9 (inclusive) were passed as ordinary resolutions and resolutions 10 to 16 (inclusive) were passed as special resolutions.

Resolution

Votes For*

% of Votes Cast

Votes Against

% of Votes Cast

Total Votes Cast

Total Votes Cast as a % of Issued Share Capital**

Votes Withheld***

1. To receive the Reports and Accounts for the year ended 31/12/2022

99,692,223

100.00

1,275

0.00

99,693,498

87.34%

57,422

2. Approval of the Annual Statement from the Chair of the Remuneration Committee and the Annual Remuneration Report

98,719,645

99.08

919,790

0.92

99,639,435

87.29%

111,485

3. Approval of the Directors' Remuneration Policy

99,013,713

99.37

626,069

0.63

99,639,782

87.30%

111,948

4. Approval of a final dividend of 45.8 pence per ordinary share

99,675,558

99.92

75,093

0.08

99,750,651

87.39%

269

5a. Re-election of P Campbell as a director

98,780,180

99.03

967,720

0.97

99,747,900

87.39%

3,020

5b. Election of R Carayol

99,556,227

99.81

191,673

0.19

99,747,900

87.39%

3,020

5c. Re-election of F A Conophy as a director

99,000,193

99.25

747,707

0.75

99,747,900

87.39%

3,020

5d. Re-election of P W Hulme as a director

99,057,915

99.31

689,985

0.69

99,747,900

87.39%

3,020

5e. Re-election of L Mitic as a director

98,780,049

99.03

967,851

0.97

99,747,900

87.39%

3,020

5f. Re-election of M J Norris as a director

99,140,275

99.39

607,625

0.61

99,747,900

87.39%

3,020

5g. Re-election of P J Ogden as a director

99,057,915

99.31

689,985

0.69

99,747,900

87.39%

3,020

5h. Re-election of R Rivaz as a director

98,805,691

99.06

942,296

0.94

99,747,987

87.39%

2,933

5i. Re-election of P Ryan as a director

97,833,680

98.08

1,914,220

1.92

99,747,900

87.39%

3,020

6. Appoint Grant Thornton UK LLP as Auditor

99,714,228

99.96

35,386

0.04

99,749,614

87.39%

1,306

7. Authorise the Directors to agree the Auditor's remuneration

99,748,583

100.00

770

0.00

99,749,353

87.39%

1,567

8. Approval of the French Sub-Plan to the Computacenter Performance Share Plan 2005

99,666,643

99.92

82,351

0.08

99,748,994

87.39%

1,926

9. Authority to allot shares

98,843,093

99.09

906,835

0.91

99,749,928

87.39%

992

10. Disapplication of pre-emption rights to the allotment of equity securities and sale of treasury shares for cash

99,551,580

99.86

136,626

0.14

99,688,206

87.34%

62,714

11. Further disapplication of pre-emption rights for the purposes of financing an acquisition or other capital investment

99,551,111

99.86

137,091

0.14

99,688,202

87.34%

62,718

12. Approval of authority to market purchase own shares

99,646,722

99.90

98,802

0.10

99,745,524

87.39%

5,396

13. Approval that a general meeting (other than an AGM) may be called on not less than 14 clear days' notice

98,494,323

98.74

1,256,252

1.26

99,750,575

87.39%

345

14. Approval of the capitalisation issue New Deferred Shares and the associated amendment of the Company's articles of association

99,745,845

100.00

4,047

0.00

99,749,892

87.39%

1,028

15.Approval of a capital reduction by way of the cancellation of the New Deferred Shares created pursuant to the authority in Resolution 14

99,745,401

100.00

4,491

0.00

99,749,892

87.39%

1,028

16. Approval of a capital reduction by way of the cancellation of the Company's capital redemption reserve

99,745,255

100.00

4,491

0.00

99,749,746

87.39%

1,174

 

Notes:

* Includes discretionary votes received

** Based on the total issued share capital of the Company as at 6.30pm on 15 May 2023 of 122,687,970 ordinary shares, each carrying one vote, and excluding 8,546,861 ordinary shares held in treasury

*** A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes for and against a resolution

 

A copy of the resolutions passed as Special Business have been submitted to the National Storage Mechanism and will shortly be available for inspection

 

These resolutions are also available within the Notice of the Annual General Meeting 2023 on the Computacenter investor website at investors.computacenter.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGBDGDUCSBDGXR
Date   Source Headline
1st May 20247:00 amRNSQ1 Trading Update
11th Apr 20241:00 pmRNS2023 Annual Financial Report & Notice of 2024 AGM
5th Apr 20247:00 amRNSDirectorate Change - Holding Announcement
4th Apr 20243:00 pmRNSDirector/PDMR Shareholding
27th Mar 20241:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20244:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20247:00 amRNSChange of Chair
20th Mar 20247:00 amRNSFinal Results 2023
5th Feb 20241:00 pmRNSBlock listing Interim Review
24th Jan 20247:00 amRNSPre-Close Trading Statement
30th Oct 202311:00 amRNSQ3 2023 Trading Update Replacement
30th Oct 20237:05 amRNSAppointment of Corporate Broker
30th Oct 20237:00 amRNSQ3 2023 Trading Update
17th Oct 20231:00 pmRNSDirector/PDMR Shareholding
12th Sep 202311:00 amRNSDirector/PDMR Shareholding
8th Sep 20237:00 amRNSHalf-year Report
8th Aug 202311:30 amRNSBlock listing Interim Review
14th Jun 202312:00 pmRNSHolding(s) in Company
7th Jun 202312:00 pmRNSDirector/PDMR Shareholding
6th Jun 20234:00 pmRNSDirector/PDMR Shareholding
17th May 20232:00 pmRNSResult of AGM
28th Apr 20237:00 amRNSQ1 2023 Trading Update
17th Apr 20231:31 pmRNS2022 Annual Financial Report & Notice of 2023 AGM
11th Apr 20233:15 pmRNSDirector/PDMR Shareholding
4th Apr 20234:00 pmRNSDirector/PDMR Shareholding
31st Mar 20231:00 pmRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSFinal Results 2022
28th Mar 20237:00 amRNSFY2022 results release date - UPDATE
14th Mar 20237:00 amRNSFY2022 results revised date; guidance unchanged
2nd Mar 202310:00 amRNSHolding(s) in Company
17th Feb 202310:00 amRNSHolding(s) in Company
9th Feb 20239:30 amRNSHolding(s) in Company
6th Feb 202311:15 amRNSBlock listing Interim Review
30th Jan 20237:00 amRNSPre-Close Trading Statement
9th Dec 202212:30 pmRNSDirectorate Change - Update
9th Dec 202212:00 pmRNSChange of Auditor
2nd Nov 20227:00 amRNSDirectorate Change
28th Oct 20227:00 amRNSQ3 2022 Trading Update
20th Oct 202210:30 amRNSDirectorate Change
27th Sep 202212:00 pmRNSHolding(s) in Company
22nd Sep 202210:30 amRNSDirector/PDMR Shareholding
12th Sep 202212:00 pmRNSDirector/PDMR Shareholding
9th Sep 20227:00 amRNSHalf-year Report
5th Aug 20229:30 amRNSBlock listing Interim Review
13th Jul 20227:00 amRNSAcquisition
19th May 20221:30 pmRNSResult of AGM
9th May 20225:30 pmRNSHolding(s) in Company
29th Apr 20227:00 amRNSQ1 2022 Trading Update
27th Apr 20229:03 amRNSCarbon Neutral Announcement
13th Apr 202212:15 pmRNS2021 Annual Financial Report & Notice of 2022 AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.